Developing drug discovery and medical businesses using microbiome science
Establishment and operation of a gut microbiota bank and research and development of a gut microbiota drug discovery program toward social implementation of gut microbiota transplantation.
Utilization of Fecal Microbiota Transplantation (FMT) platform and bioinformatics research todevelop multiple pipeline and exploratory studies for gastrointestinal andimmune system diseases
Company name
Metagen Therapeutics, Inc.
Type of business
Medical(medical devices, drug discovery)
Representatives
Taku Nakahara
Establishing a company
January 2020
Investment announcement date
April 2023
Capitalist
Jun Hayashi
HP
https://www.metagentx.com/Phasing
Early